.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Alzheimer’s disease presents a significant challenge for modern medicine, creating an urgent need for neuroregenerative treatments. Recent research indicates that NeuroD1 gene therapy effectively repairs functional brain damage in non-human primate models. This innovative approach targets hippocampal degeneration, which typically leads to severe memory loss.
Scientists utilized an adeno-associated virus (AAV) vector to deliver the NeuroD1 gene into the hippocampus. Consequently, the therapy prevented neuronal damage and significantly reduced neuroinflammation. Moreover, researchers observed a restoration of the blood-brain barrier and vascular integrity. These improvements coincided with enhanced spatial working memory and stabilized hippocampal glucose metabolism.
The study employed advanced imaging, including MRI and FDG PET scans, to monitor brain changes. Results showed that the treatment inhibited hippocampal atrophy. Furthermore, transcriptome analysis confirmed the upregulation of neuronal function and synaptic transmission pathways. Because the primate model closely reflects human pathology, these findings offer substantial hope for future clinical applications.
It acts as a master transcription factor that facilitates the conversion of glial cells into functional neurons, thereby repairing damaged brain circuits.
The therapy restores CSF AD biomarker levels to more normal ranges, suggesting a systemic improvement in brain health and pathology.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Jiang Z et al. A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair in Alzheimer's Disease-Like Non-Human Primate Model. Adv Sci (Weinh). 2026 Mar 10. doi: 10.1002/advs.202520239. PMID: 41806359.
Ge L-J, et al. In vivo Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates. Front Cell Dev Biol. 2020;8:590008.
Chen YC, et al. A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion. Mol Ther. 2020;28(1):217-234.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research demonstrates that NeuroD1 AAV-based gene therapy repairs brain function, inhibits atrophy, and improves memory in Alzheimer's primate models....
5 months ago
A new study reveals that ultra-low-dose photon-counting detector CT achieves 90% radiation reduction in coronary artery calcium scoring while maintaining excellent correlation with standard scans, outperforming angiography-derived virtual non-contrast images.
Today
A retrospective cohort study reveals that simulation-free vaginal cuff brachytherapy achieves low 5-year vaginal recurrence rates comparable to simulation-verified protocols in high-intermediate risk endometrial cancer, supporting streamlined radiation oncology workflows.
Today
A recent study demonstrates that the Clear Motion Cardiac motion-correction algorithm significantly enhances mid-diastolic coronary CT angiography image quality on 320-detector row CT, boosting diagnostic readability from 83.1% to 92.8% without altering patient cardiac physiology.
Today
A breakthrough study reveals how the agricultural fungicide thiram disrupts hepatic and tibial calcium homeostasis through ER stress and IP3R1/VDAC1 hyperactivation, uncovering a critical liver-bone axis of systemic toxicity.
Today
A new study in JMIR AI validates a unified multistage framework to detect and mitigate AI bias in healthcare, revealing critical trade-offs between demographic fairness, calibration, and discrimination.
Today
